Fundraising Fox

Peter Goodfellow

Investor

Senior Advisor at Abingworth

Find your path to Peter

50 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.

Carlos PayaunlockedPeter: together at Abingworth
×11Peter: together at Abingworth

About

Peter Goodfellow previously served as Senior Vice President for Discovery Research at GlaxoSmithKline and held the Balfour chair in genetics at Cambridge University, along with research positions at the Imperial Cancer Research Fund. He chaired the boards of GammaDelta Therapeutics and Adaptate Biotherapeutics, both Abingworth portfolio companies. He holds doctorates from Oxford and Bristol Universities and is a Fellow of EMBO, the Academy of Medical Sciences, and the Royal Society.

Invests in

Biotech

Investments

Board seats

Adaptate BiotherapeuticsGammaDelta Therapeutics

Per the firm's website.

Colleagues at Abingworth

Frequently asked questions

Who is Peter Goodfellow?
Peter Goodfellow previously served as Senior Vice President for Discovery Research at GlaxoSmithKline and held the Balfour chair in genetics at Cambridge University, along with research positions at the Imperial Cancer Research Fund. He chaired the boards of GammaDelta Therapeutics and Adaptate Biotherapeutics, both Abingworth portfolio companies. He holds doctorates from Oxford and Bristol Universities and is a Fellow of EMBO, the Academy of Medical Sciences, and the Royal Society.
Where does Peter Goodfellow work?
Peter Goodfellow is Senior Advisor at Abingworth.
What does Peter Goodfellow invest in?
Peter Goodfellow invests in Biotech.
What boards does Peter Goodfellow sit on?
Peter Goodfellow holds tracked board seats at Adaptate Biotherapeutics, GammaDelta Therapeutics.